Maxwell Skor

Stock Analyst at Morgan Stanley

(2.85)
# 1,852
Out of 5,017 analysts
6
Total ratings
80%
Success rate
20.25%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Maxwell Skor

Insmed
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $126$144
Current: $163.94
Upside: -12.16%
Ascendis Pharma
Jul 3, 2025
Assumes: Overweight
Price Target: $250
Current: $208.43
Upside: +19.94%
Sana Biotechnology
Jul 3, 2025
Assumes: Overweight
Price Target: $12
Current: $4.35
Upside: +176.18%
TScan Therapeutics
Mar 14, 2025
Assumes: Overweight
Price Target: $10
Current: $2.20
Upside: +354.55%
Invivyd
Nov 20, 2024
Maintains: Overweight
Price Target: $9.5$3.55
Current: $1.88
Upside: +88.83%